Advertisement

Varicella-zoster virus immunity and prevention: a conference perspective

  • S. E. Straus
Conference paper

Summary

This report offers a concise overview of the VZV Conference, highlighting recent developments in the field and speculating on areas of greatest opportunity and need for future work. The goal of eradicating VZV disease will be facilitated by a multifaceted research agenda directed at a fuller comprehension of how the virus replicates, spreads and persists, and how it eludes host immune responses.

Keywords

Herpes Zoster Varicella Vaccine Simian Varicella Virus Human Dorsal Root Ganglion Live Attenuate Varicella Vaccine 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Brunell PA, Ren LC, Cohen JI, Straus SE (1999) Viral gene expression in rat trigeminal ganglia following neonatal infection with varicella-zoster virus. J Med Virol 58: 286–290PubMedCrossRefGoogle Scholar
  2. 2.
    Culbertson WW, Blumenkranz MS, Pepose JS, Stewart JA, Curtin VT (1986) Varicella zoster virus is a cause of the acute retinal necrosis syndrome. Ophthalmology 93: 559–569PubMedGoogle Scholar
  3. 3.
    Garnett GP, Ferguson NM (1996) Predicting the effect of varicella vaccine on subsequent cases of zoster and varicella. Rev Med Virol 6: 151–161PubMedCrossRefGoogle Scholar
  4. 4.
    Gilden DH, Murray RS, Wellish M, Kleinschmidt-deMasters BK, Vafai A (1988) Chronic progressive varicella-zoster virus encephalitis in an AIDS patient. Neurology 38: 1150–1153PubMedCrossRefGoogle Scholar
  5. 5.
    Hope-Simpson RE (1975) Postherpetic neuralgia. J R Coll Gen Pract 25: 571–575PubMedGoogle Scholar
  6. 6.
    Lungu O, Annunziato PW, Gershon A, Staugaitis SM, Josefson D, LaRussa P, Silverstein SJ (1995) Reactivated and latent varicella-zoster virus in human dorsal root ganglia. Proc Natl Acad Sci USA 92: 10980–10984PubMedCrossRefGoogle Scholar
  7. 7.
    Lungu O, Panagiotidis CA, Annunziato PW, Gershon AA, Silverstein SJ (1998) Aberrant intracellular localization of varicella-zoster virus regulatory proteins during latency. Proc Natl Acad Sci USA 95: 7080–7085PubMedCrossRefGoogle Scholar
  8. 8.
    Kennedy PG, Grinfeld E, Gow JW (1998) Latent varicella-zoster virus is located predominantly in neurons in human trigeminal ganglia. Proc Natl Acad Sci USA 95: 4658–4662PubMedCrossRefGoogle Scholar
  9. 8a.
    Krause PR, Klinman DM (2000) Varicella vaccination: evidence for frequent reactivation of the vaccine strain in healthy children. Nature Med 6: 451–454PubMedCrossRefGoogle Scholar
  10. 9.
    Krause PR, Straus SE (1999) Herpesvirus vaccines. Development, controversies, and applications. Infect Dis Clin North Am 13: 61–81PubMedCrossRefGoogle Scholar
  11. 10.
    LaRussa P, Steinberg S, Arvin A, Dwyer D, Burgess M, Menegus M, Rekrut K, Yamanishi K, Gershon A (1998) Polymerase chain reaction and restriction fragment length polymorphism analysis of varicella-zoster virus isolates from the United States and other parts of the world. J Infect Dis 178 [Suppl 1]: S64–S66PubMedCrossRefGoogle Scholar
  12. 11.
    Levin MJ, Barber D, Goldblatt E, Jones M, laFleur B, Chan C, Stinson D, Zerbe GO, Hayward AR (1998) Use of a live attenuated varicella vaccine to boost varicella-specific immune responses in seropositive people 55 years of age and older: duration of booster effect. J Infect Dis 178 [Suppl] S109–S112PubMedCrossRefGoogle Scholar
  13. 12.
    Moffat JF, Zerboni L, Sommer MH, Heineman TC, Cohen JI, Kaneshima H, Arvin AM (1998) The ORF47 and ORF66 putative protein kinases of varicella-zoster virus determine tropism for human T cells and skill in the SCID-hu mouse. Proc Natl Acad Sci USA 95: 11969–11974PubMedCrossRefGoogle Scholar
  14. 13.
    Myers MG, Stanberry LR, Edmond BJ (1985) Varicella-zoster virus infection of strain 2 guinea pigs. J Infect Dis 151: 106–113PubMedCrossRefGoogle Scholar
  15. 14.
    Sadzot-Delvaux C, Debrus S, Nikkels A, Piette J, Rentier B (1995) Varicella-zoster virus latency in the adult rat is a useful model for human latent infection. Neurology 45 [Supp l8]: S18–S20PubMedCrossRefGoogle Scholar
  16. 15.
    Silverstein S, Straus SE (2000) The pathogenesis of latency and reactivation: the ins and outs of VZV. In: Arvin AM, Gershon AA (eds) Varicella-zoster: basic virology and clinical management. Cambridge University Press, CambridgeGoogle Scholar
  17. 16.
    Soike KF (1992) Simian varicella virus infection in African and Asian monkeys. The potential for development of antivirals for animal diseases. Ann NY Acad Sci 653: 323–333PubMedCrossRefGoogle Scholar
  18. 17.
    Stemmer SM, Kinsman K, Tellschow S, Jones RB (1993) Fatal noncutaneous visceral infection with varicella-zoster virus in a patient with lymphoma after autologous bone marrow transplantation. Clin Infect Dis 16: 497–499PubMedCrossRefGoogle Scholar
  19. 18.
    Takahashi M, Okuno Y, Otsuka T, Osame J, Takamizawa A (1975) Development of a live attenuated varicella vaccine. Biken J 18: 25–33PubMedGoogle Scholar
  20. 19.
    Takahashi M, Otsuka T, Okuna Y, Asano Y, Yazaki T (1974) Live vaccine used to prevent the spread of varicella in children in hospital. Lancet 2: 1288–1290PubMedCrossRefGoogle Scholar
  21. 20.
    Wilson A, Sharp M, Koropchak CM, Ting SF, Arvin AM (1992) Subclinical varicellazoster virus viremia, herpes zoster, and T lymphocyte immunity to varicella-zoster viral antigens after bone marrow transplantation. J Infect Dis 165: 119–126PubMedCrossRefGoogle Scholar
  22. 21.
    Yoshida M, Tamura T, Hiruma M (1999) Analysis of strain variation of R1 repeated structure in varicella-zoster virus DNA by polymerase chain reaction. J Med Virol 58: 76–78PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Wien 2001

Authors and Affiliations

  • S. E. Straus
    • 1
  1. 1.Laboratory of Clinical InvestigationNational Institute of Allergy and Infectious Diseases, National Institutes of HealthBethesdaUSA

Personalised recommendations